Menu

• Ask a Health Expert about CEREBRAL HYPOPERFUSION
• Post Your Side Effect related to CEREBRAL HYPOPERFUSION
• CEREBRAL HYPOPERFUSION and FDA Warnings
• CEREBRAL HYPOPERFUSION in Patients Wiki
• Report CEREBRAL HYPOPERFUSION in Drug Side Effect Survey

CEREBRAL HYPOPERFUSION side effect

What is CEREBRAL HYPOPERFUSION ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Lodoz Side Effects Report #5712116-8
Consumer or non-health professional from FRANCE reported LODOZ problem on Mar 28, 2008. Male patient was treated with LODOZ. After drug was administered, patient experienced the following problems/side effects: cerebral hypoperfusion, congenital bladder anomaly, congenital central nervous system anomaly, foetal disorder, foetal growth retardation, multiple congenital abnormalities, potter's syndrome, . LODOZ dosage: unknown. During the same period patient was treated with OLMESARTAN MEDOXOMIL. Patient was hospitalized. Patient died.

Saizen Side Effects Report #5291363-6
SAIZEN problem was reported by a Physician from TURKEY on Mar 20, 2007. Male patient, child 10 years of age, was diagnosed with growth hormone deficiency and was treated with SAIZEN. After drug was administered, patient experienced the following problems/side effects: cerebral hypoperfusion, tourette's disorder, . SAIZEN dosage: 0.03 MG/KG, 1 IN 1 DAYS;. Patient recovered.

Sumatriptan Side Effects Report #5314596-9
Consumer or non-health professional from SWITZERLAND reported SUMATRIPTAN SUCCINATE problem on Apr 17, 2007. Male patient, 37 years of age, was diagnosed with migraine and was treated with SUMATRIPTAN SUCCINATE. After drug was administered, patient experienced the following problems/side effects: cerebral hypoperfusion, cerebral infarction, disinhibition, hypertension, obsessive-compulsive disorder, skin lesion, speech disorder, . SUMATRIPTAN SUCCINATE dosage: unknown. During the same period patient was treated with PAROXETINE HYDROCHLORIDE, QUETIAPINE FUMARATE. Patient recovered.

Lamisil Side Effects Report #5281543-8
LAMISIL problem was reported by a Physician from UNITED STATES on Mar 21, 2007. Female patient, 30 years of age, was diagnosed with onychomycosis and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: cerebral hypoperfusion, chest discomfort, headache, lyme disease, myalgia, neck pain, . LAMISIL dosage: 250 MG, QD. Patient recovered.


Strattera Side Effects Report #5482922-6
Physician from UNITED STATES reported STRATTERA problem on Sept 27, 2007. Female patient was diagnosed with attention deficit/hyperactivity disorder and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: blood homocysteine increased, cerebral hypoperfusion, haemorrhagic stroke, hemiplegia, overdose, . STRATTERA dosage: 40 MG, 2/D. Patient was hospitalized and became disabled. Patient recovered.

Relpax Side Effects Report #5417731-7
RELPAX problem was reported by a Pharmacist from UNITED STATES on Aug 15, 2007. Female patient, weighting 117.0 lb, was diagnosed with migraine and was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: cardiac disorder, cerebral hypoperfusion, cerebral vasoconstriction, confusional state, disorientation, vomiting, . RELPAX dosage: 40MG PO. During the same period patient was treated with INDERAL, LEVOTHYROXINE, ESTRADIOL, DICYCLOMINE. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #5325386-5
Physician from JAPAN reported TRISENOX problem on Apr 24, 2007. Male patient, 73 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with TRISENOX. After drug was administered, patient experienced the following problems/side effects: altered state of consciousness, cerebral hypoperfusion, cerebral infarction, condition aggravated, dysarthria, dysphagia, electrocardiogram qt prolonged, haemodialysis, renal failure, . TRISENOX dosage: 10.05 MG QD INTRAVENOUS DRIP. During the same period patient was treated with TRETINOIN, GABEXATE MESILATE, DALTEPARIN, GABEXATE MESILATE, CALCIUM GLUCONATE. Patient recovered.

Valproate Side Effects Report #5661529-1
VALPROATE problem was reported by a Health Professional from AUSTRALIA on Mar 07, 2008. Female patient, 38 years of age, was diagnosed with convulsion and was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: atrophy, blood creatine phosphokinase increased, cerebral hypoperfusion, chorea, coordination abnormal, depression, dysarthria, dyskinesia, dysphagia, . VALPROATE dosage: unknown. During the same period patient was treated with CARBAMAZEPINE. Patient died.

Valproate Side Effects Report #5672388-5
Health Professional from AUSTRALIA reported VALPROATE problem on Mar 17, 2008. Female patient, 38 years of age, was diagnosed with convulsion and was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: atrophy, blood creatine phosphokinase increased, cerebral hypoperfusion, chorea, coordination abnormal, depression, dysarthria, dyskinesia, dysphagia, . VALPROATE dosage: unknown. During the same period patient was treated with CARBAMAZEPINE. Patient died.


Trisenox Side Effects Report #5391723-9
TRISENOX problem was reported by a Physician from JAPAN on July 10, 2007. Male patient was diagnosed with acute promyelocytic leukaemia and was treated with TRISENOX. After drug was administered, patient experienced the following problems/side effects: altered state of consciousness, blood creatinine increased, cerebral hypoperfusion, cerebral infarction, condition aggravated, dysarthria, dysphagia, electrocardiogram qt prolonged, haemodialysis, . TRISENOX dosage: 10.05 MG QD INTRAVENOUS DRIP. During the same period patient was treated with TRETINOIN, GABEXATE MESILATE, DALTEPARIN, GABEXATE MESILATE, CALCIUM GLUCONATE. Patient recovered.

Trisenox Side Effects Report #5391723-9
Physician from JAPAN reported TRISENOX problem on July 10, 2007. Male patient was diagnosed with acute promyelocytic leukaemia and was treated with TRISENOX. After drug was administered, patient experienced the following problems/side effects: altered state of consciousness, blood creatinine increased, cerebral hypoperfusion, cerebral infarction, condition aggravated, dysarthria, dysphagia, electrocardiogram qt prolonged, haemodialysis, . TRISENOX dosage: 10.05 MG QD INTRAVENOUS DRIP. During the same period patient was treated with TRETINOIN, GABEXATE MESILATE, DALTEPARIN, GABEXATE MESILATE, CALCIUM GLUCONATE. Patient recovered.